These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of sequential oligopeptide carriers (SOCn) in the design of potent Leishmania gp63 immunogenic peptides. Tsikaris V; Sakarellos C; Sakarellos-Daitsiotis M; Cung MT; Marraud M; Konidou G; Tzinia A; Soteriadou KP Pept Res; 1996; 9(5):240-7. PubMed ID: 9000250 [TBL] [Abstract][Full Text] [Related]
5. A fibronectin-related synthetic peptide, Pro-Ala-Ser-Ser, inhibits fibronectin binding to the cell surface, fibronectin-promoted cell migration in vitro, and cell migration in vivo. Katow H; Yazawa S; Sofuku S Exp Cell Res; 1990 Sep; 190(1):17-24. PubMed ID: 2387327 [TBL] [Abstract][Full Text] [Related]
6. The CS5 peptide is a second site in the IIICS region of fibronectin recognized by the integrin alpha 4 beta 1. Inhibition of alpha 4 beta 1 function by RGD peptide homologues. Mould AP; Komoriya A; Yamada KM; Humphries MJ J Biol Chem; 1991 Feb; 266(6):3579-85. PubMed ID: 1750929 [TBL] [Abstract][Full Text] [Related]
7. Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes. Russell DG; Wright SD J Exp Med; 1988 Jul; 168(1):279-92. PubMed ID: 3294332 [TBL] [Abstract][Full Text] [Related]
8. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. Humphries MJ; Akiyama SK; Komoriya A; Olden K; Yamada KM J Cell Biol; 1986 Dec; 103(6 Pt 2):2637-47. PubMed ID: 3025221 [TBL] [Abstract][Full Text] [Related]
9. The major surface protein of Leishmania promastigotes is a fibronectin-like molecule. Rizvi FS; Ouaissi MA; Marty B; Santoro F; Capron A Eur J Immunol; 1988 Mar; 18(3):473-6. PubMed ID: 2965651 [TBL] [Abstract][Full Text] [Related]
10. Antimetastatic activities of synthetic Arg-Gly-Asp-Ser (RGDS) and Arg-Leu-Asp-Ser (RLDS) peptide analogues and their inhibitory mechanisms. Fujii H; Komazawa H; Mori H; Kojima M; Itoh I; Murata J; Azuma I; Saiki I Biol Pharm Bull; 1995 Dec; 18(12):1681-8. PubMed ID: 8787788 [TBL] [Abstract][Full Text] [Related]
11. Synthetic Arg-Gly-Asp-Ser analogues of the cell recognition site of fibronectin that retain antimetastatic and anti-cell adhesive properties. Komazawa H; Saiki I; Aoki M; Kitaguchi H; Satoh H; Kojima M; Ono M; Itoh I; Azuma I Biol Pharm Bull; 1993 Oct; 16(10):997-1003. PubMed ID: 8287052 [TBL] [Abstract][Full Text] [Related]
12. Antibodies raised against synthetic peptides from the Arg-Gly-Asp-containing region of the Leishmania surface protein gp63 cross-react with human C3 and interfere with gp63-mediated binding to macrophages. Russell DG; Talamas-Rohana P; Zelechowski J Infect Immun; 1989 Feb; 57(2):630-2. PubMed ID: 2912899 [TBL] [Abstract][Full Text] [Related]
13. Involvement of Leishmania donovani major surface glycoprotein gp63 in promastigote multiplication. Pandey S; Chakraborti P; Sharma R; Bandyopadhyay S; Sarkar D; Adhya S J Biosci; 2004 Mar; 29(1):15-22. PubMed ID: 15286399 [TBL] [Abstract][Full Text] [Related]
14. Leishmania gp63 molecule implicated in cellular adhesion lacks an Arg-Gly-Asp sequence. Miller RA; Reed SG; Parsons M Mol Biochem Parasitol; 1990 Mar; 39(2):267-74. PubMed ID: 2320059 [TBL] [Abstract][Full Text] [Related]
15. Anti-(Arg-Gly-Asp-Ser) antibody and its interaction with fibronectin, fibrinogen and platelets. Cierniewski CS; Swiatkowska M; Poniatowski J; Niewiarowska J Eur J Biochem; 1988 Oct; 177(1):109-15. PubMed ID: 2460346 [TBL] [Abstract][Full Text] [Related]
16. Fibronectin receptor of human macrophages recognizes the sequence Arg-Gly-Asp-Ser. Wright SD; Meyer BC J Exp Med; 1985 Aug; 162(2):762-7. PubMed ID: 3160809 [TBL] [Abstract][Full Text] [Related]
17. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. Pierschbacher MD; Ruoslahti E J Biol Chem; 1987 Dec; 262(36):17294-8. PubMed ID: 3693352 [TBL] [Abstract][Full Text] [Related]
18. Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin. Rogers SL; Letourneau PC; Peterson BA; Furcht LT; McCarthy JB J Cell Biol; 1987 Sep; 105(3):1435-42. PubMed ID: 2958484 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi infection inhibited by peptides modeled from a fibronectin cell attachment domain. Ouaissi MA; Cornette J; Afchain D; Capron A; Gras-Masse H; Tartar A Science; 1986 Oct; 234(4776):603-7. PubMed ID: 3094145 [TBL] [Abstract][Full Text] [Related]
20. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. Gartner TK; Bennett JS J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]